Home Featured Page 161

Featured

Latest

Backed by $11M NIDA Grant, Harvard Moves Forward on Ibogaine for Opioid Use Disorder Research

Keeping Up with the Feds: From FDA to HRSA, Washington Backs Psychedelics

The Rush for Iboga Looks Different from Gabon

FDA Issues Final Psychedelics Guidance, Schedules September Hearing on the Future of Psychedelic Therapies

Pα+ Psychedelic Bulletin #227: A Closer Look at Compass’ 6-Month Data; AtaiBeckley Deal Update; ‘Rysanso’ Brand MDMA?

Small Pharma Completes Enrollment in Phase IIa DMT-Assisted Psychotherapy Clinical Trial...

Numinus Now Offers Ketamine-Assisted Therapy in Toronto

Clearmind Medicine Announces Share-Based Payment for one of the Company’s Consultants

Braxia Scientific Announces Court Approval of Class Action Settlement in Canada

PharmaTher Announces Late-Breaking Abstract Presentation of Positive Efficacy and Safety Data...

PT356 – Brom Rector – Investing in Psychedelics and The Rush...

Revive Therapeutics Provides Update on the Psilocybin Clinical Study for Methamphetamine...

Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SEVALENT™

Silo Pharma Announces Implementation of 1-for-50 Reverse Stock Split in Preparation...

MindMed Announces Compliance with Nasdaq Listing Requirements

EDITOR PICKS

Backed by $11M NIDA Grant, Harvard Moves Forward on Ibogaine for...

Keeping Up with the Feds: From FDA to HRSA, Washington Backs...

The Rush for Iboga Looks Different from Gabon

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Backed by $11M NIDA Grant, Harvard Moves Forward on Ibogaine for Opioid Use Disorder Research

Keeping Up with the Feds: From FDA to HRSA, Washington Backs Psychedelics

The Rush for Iboga Looks Different from Gabon

FDA Issues Final Psychedelics Guidance, Schedules September Hearing on the Future of Psychedelic Therapies

Pα+ Psychedelic Bulletin #227: A Closer Look at Compass’ 6-Month Data; AtaiBeckley Deal Update; ‘Rysanso’ Brand MDMA?

Small Pharma Completes Enrollment in Phase IIa DMT-Assisted Psychotherapy Clinical Trial...

Numinus Now Offers Ketamine-Assisted Therapy in Toronto

Clearmind Medicine Announces Share-Based Payment for one of the Company’s Consultants

Braxia Scientific Announces Court Approval of Class Action Settlement in Canada

PharmaTher Announces Late-Breaking Abstract Presentation of Positive Efficacy and Safety Data...

PT356 – Brom Rector – Investing in Psychedelics and The Rush...

Revive Therapeutics Provides Update on the Psilocybin Clinical Study for Methamphetamine...

Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SEVALENT™

Silo Pharma Announces Implementation of 1-for-50 Reverse Stock Split in Preparation...

MindMed Announces Compliance with Nasdaq Listing Requirements

EDITOR PICKS

Backed by $11M NIDA Grant, Harvard Moves Forward on Ibogaine for...

Keeping Up with the Feds: From FDA to HRSA, Washington Backs...

The Rush for Iboga Looks Different from Gabon

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY